In the highest-dose group, 16% of people stopped taking retatrutide because of side effects, while no one in the placebo group stopped for this reason
Gastrointestinal agents: While yet controversial and difficult to assess, many studies point to an increased incidence of gastrointestinal issues (such as chronic diarrhea, constipation, or acid reflux disease) in individuals with ASD
They added that societal challenges and environmental factors can play a major role
Avoid sharing the product with others to maintain hygiene
Type 2 diabetes is associated with deficiency in SCFA production
[115] According to Novo Nordisk, under the ChinaSwitzerland Free Trade Agreement, semaglutide is subject to regulatory data protection in China until April 2027, and their Swiss subsidiary holds those rights exclusively